Cyclacel Pharmaceuticals, Inc. (CYCC) Financials

CYCC Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 12.4 million 8.1 million
2023-06-30 16.4 million 6.8 million
2023-03-31 22.1 million 7.4 million
2022-12-31 27.5 million 12.0 million

CYCC Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -4.0 million 391000
2023-06-30 -1.3 million 359000
2023-03-31 -6.9 million 401000
2022-12-31 -5.2 million 387000

CYCC Net Income

No data available :(

CYCC Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 5.9 million - 52000
2023-06-30 10.2 million - 66000
2023-03-31 11.4 million - 80000
2022-12-31 18.3 million - 106000

CYCC Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 12.6 million
2023-06-30 12.6 million
2023-03-31 12.5 million
2022-12-31 12.5 million

CYCC Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 5.2 million 1.6 million -
2023-06-30 - 4.7 million 1.6 million -
2023-03-31 6000 5.7 million 1.6 million -
2022-12-31 2 6.7 million 2.1 million -

CYCC Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 16000 7000
2023-06-30 373000 372627
2023-03-31 - 8000
2022-12-31 - 8000

CYCC

Price: $2

52 week price:
1.36
13.20

Earnings Per Share: -26.75 USD

P/E Ratio: -0.07

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 123100

Ebitda: -2.1 million

Market Capitalization: 2.8 million

Links: